Sciwind Publishes Diabetes Drug Trial in Nature Communications
January 29, 2026 | 15:49
The biopharmaceutical company released phase three clinical data for its type two diabetes treatment ecnoglutide in the peer-reviewed scientific journal.
Mobile Version